|
Oct 9
|
XORTX Initiates Precision Medicine Program
|
|
Sep 13
|
XORTX Announces Results of Annual and Special Meeting of Shareholders
|
|
Sep 12
|
XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A
|
|
Apr 8
|
XORTX Announces Participation in Spring 2024 Investor Conferences
|
|
Jan 15
|
XORTX Announces $2 Million Public Offering
|
|
Jan 3
|
XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease
|
|
Jan 2
|
XORTX Welcomes New Member to the Board of Directors
|
|
Nov 30
|
XORTX Announces US ATM Offering
|
|
Nov 29
|
XORTX Meets Nasdaq Continued Listing Requirements
|
|
Sep 28
|
XORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2023
|